Biora AB appoints a new CFO

Report this content

Biora AB appoints a new CFO Svante Lundell has been appointed as the new Chief Financial Officer of Biora AB effective September 1st 2002. He replaces Kerstin Pålsson who has decided to resign from her position as CFO of the Company due to family reasons. Ms. Pålsson joined Biora as Group Controller in 1997. Svante Lundell has held a number of executive financial positions in Sweden and Europe for US based companies throughout his career. He has most recently practiced as a financial consultant focusing on financial analysis. Prior to that, he was Vice President, Finance Europe at Hercules Inc., a US specialty chemical company. Donna Janson, President and CEO of Biora commented on the appointment: " I am very pleased that within a short time frame we have been able to appoint a new CFO who has considerable international experience and knowledge. As Svante Lundell will be able to join Biora on September 1st, we will be able to make the transition between CFOs smoothly and effectively". Biora develops manufactures and sells biology-based products for the treatment of dental diseases. The principal product, Emdogain®Gel, which is approved for sale in Europe, North America and Japan naturally regenerates the supporting structure that the tooth has lost due to periodontal disease. Biora's American Depository Shares are quoted in the OTC market in the US and Biora's ordinary shares are listed on the "O-list" of the Stockholm Stock Exchange in Sweden. This press release may contain certain forward- looking statements that relate to future events or future business and financial performance. Such statements can only be predictions and the actual events or results may differ from those discussed. The Company cautions that these statements are subject to important factors that could cause actual results to differ materially from those expressed or implied in such forward looking statements and are more fully discussed in periodic reports filed with Securities and Exchange Commission. For further information, please contact: - Tommie Johansson, Corporate Communications and Investor Relations, Biora +46 70 32 21 365 - Donna Janson, President and CEO of Biora, tel: +46- 40-32 12 28 - ------------------------------------------------------------ This information was brought to you by Waymaker The following files are available for download: